Biothera Pharmaceuticals, Inc. Employee Directory
Biotechnology ResearchMinnesota, United States51-200 Employees
Biothera Pharmaceuticals, Inc. is a privately held biotechnology company focused on immuno-oncology research, developing Imprime PGG in combination with immune checkpoint inhibitors for multiple cancer indications. Imprime PGG is a biologic innate immune modulator designed to activate the immune system and coordinate anti-cancer immune responses, with preclinical data suggesting enhanced efficacy when paired with CPIs and other targeted antibodies. The company maintains clinical research agreements with Merck, Genentech and AstraZeneca to evaluate Imprime PGG in combination with CPIs across various cancers, including metastatic triple-negative breast cancer, head and neck cancer, and colorectal cancer. Clinical experience with Imprime PGG has shown tolerability in trials involving more than 500 subjects, including over 400 cancer patients. The company is based in Eagan, Minnesota, at 3388 Mike Collins Drive Suite a, and employs 51-200 people; its website is https://biothera.com. In 2020, Biothera announced integration with Hibercell, and in 2021 Hibercell announced its acquisition of Biothera.